Updates are available Correction dated 2022-10-03
Click to view Correction: https://doi.org/10.1038/s41467-022-33097-z
-
Authors
Sajuthi, Satria P. https://orcid.org/0000-0001-9598-7298
Everman, Jamie L. https://orcid.org/0000-0002-1935-4672
Jackson, Nathan D.
Saef, Benjamin
Rios, Cydney L.
Moore, Camille M.
Mak, Angel C. Y. https://orcid.org/0000-0002-5372-4198
Eng, Celeste
Fairbanks-Mahnke, Ana
Salazar, Sandra
Elhawary, Jennifer
Huntsman, Scott
Medina, Vivian
Nickerson, Deborah A.
Germer, Soren https://orcid.org/0000-0002-6038-8508
Zody, Michael C. https://orcid.org/0000-0001-6594-7199
Abecasis, Gonçalo https://orcid.org/0000-0003-1509-1825
Kang, Hyun Min
Rice, Kenneth M. https://orcid.org/0000-0002-3071-7278
Kumar, Rajesh
Zaitlen, Noah A.
Oh, Sam https://orcid.org/0000-0002-2815-6037
,
Rodríguez-Santana, José
Burchard, Esteban G.
Seibold, Max A. https://orcid.org/0000-0002-8685-4263
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL135156, P01 HL132821, P01 HL107202, R01 HL117004)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Institute on Minority Health and Health Disparities (R01 MD010443)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Defense (DOD Grant W81WH-16-2-0018)
- License Information
-
More Information
Article History
Received: 8 September 2021
Accepted: 10 February 2022
First Online: 28 March 2022
Change Date: 3 October 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-022-33097-z
Competing interests
: H.M.K. is an employee of Regeneron Pharmaceuticals and owns stock and stock options for Regeneron Pharmaceuticals. G.A. is an employee of Regeneron Pharmaceuticals and owns stock and stock options for Regeneron Pharmaceuticals. M.C.Z. owns stock in ThermoFisher and Merck. All other authors declare no competing interests.
